KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Other Non-Current Liabilities (2016 - 2020)

Palvella Therapeutics (PVLA) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $6000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $6000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $6000.0, a N/A change, with the full-year FY2020 number at $6000.0, changed N/A from a year prior.
  • Other Non-Current Liabilities was $6000.0 for Q4 2020 at Palvella Therapeutics, down from $12.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $12.3 million in Q2 2019 to a low of $6000.0 in Q4 2020.
  • A 5-year average of $1.6 million and a median of $40902.5 in 2016 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: crashed 86.59% in 2016, then skyrocketed 37656.25% in 2019.
  • Palvella Therapeutics' Other Non-Current Liabilities stood at $47000.0 in 2016, then fell by 21.28% to $37000.0 in 2017, then dropped by 27.03% to $27000.0 in 2018, then skyrocketed by 44648.15% to $12.1 million in 2019, then tumbled by 99.95% to $6000.0 in 2020.
  • Per Business Quant, the three most recent readings for PVLA's Other Non-Current Liabilities are $6000.0 (Q4 2020), $12.1 million (Q3 2019), and $12.3 million (Q2 2019).